SEC Form 4 research
| Issuer | Inhibitor Therapeutics, Inc. |
|---|---|
| Tickers | CBTEQ, HPPI, INTI, CBTE, CBTI |
| Reporting owners | 36 |
| Officers and directors | 10 |
| Last public filing | 2026-08-05 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-04 | 2026-05-04 | OSMAN RONALD E, Ronald E. Osman Irrevocable Trust III under Agreement dated May 13, 2012 | A | 50,000 | $0 | Not reported |
| 2026-08-04 | 2026-05-04 | Yanez Michelle | A | 50,000 | $0 | Not reported |
| 2026-08-04 | 2026-05-04 | SEARS SAMUEL P JR | A | 50,000 | $0 | Not reported |
| 2026-08-04 | 2026-05-04 | ODONNELL FRANCIS E JR | A | 50,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.